Drug Shortage Report for RECOMBIVAX HB
| Report ID | 43284 |
| Drug Identification Number | 02243676 |
| Brand name | RECOMBIVAX HB -(PRESERVATIVE FREE) |
| Common or Proper name | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 5MCG/0.5ML 1DOSE VIAL |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-03-21 |
| Actual start date | 2018-03-19 |
| Estimated end date | 2020-12-31 |
| Actual end date | 2020-09-10 |
| Shortage status | Resolved |
| Updated date | 2020-09-11 |
| Company comments | Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.